Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Dalgarno

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Structure-based design and synthesis of a novel class of Src SH2 inhibitorsJ L Buchanan, R S Bohacek, G P Luke, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 1999
An efficient synthesis of a 4'-phosphonodifluoromethyl-3'-formyl-phenylalanine containing SRC SH2 ligandW C Shakespeare, R S Bohacek, S S Narula, et al.
Biochimica Et Biophysica Acta|December 7, 1984
The nature of the trifluoperazine binding sites on calmodulin and troponin-CD C Dalgarno, R E Klevit, B A Levine, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Selective inhibition of Src SH2 by a novel thiol-targeting tricarbonyl-modified inhibitor and mechanistic analysis by (1)H/(13)C NMR spectroscopyR Sundaramoorthi, C Siedem, C B Vu, et al.
Journal of Medicinal Chemistry|October 29, 2000
Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domainW C Shakespeare, R S Bohacek, M D Azimioara, et al.
Journal of Medicinal Chemistry|March 23, 2001
X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitorR S Bohacek, D C Dalgarno, M Hatada, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discoveryT K Sawyer, W C Shakespeare, Y Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domainN Kawahata, M G Yang, G P Luke, et al.
Bone|February 13, 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorptionS M Violette, W Guan, C Bartlett, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Structure-based design and synthesis of a novel class of Src SH2 inhibitorsJ L Buchanan, R S Bohacek, G P Luke, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 1999
An efficient synthesis of a 4'-phosphonodifluoromethyl-3'-formyl-phenylalanine containing SRC SH2 ligandW C Shakespeare, R S Bohacek, S S Narula, et al.
Biochimica Et Biophysica Acta|December 7, 1984
The nature of the trifluoperazine binding sites on calmodulin and troponin-CD C Dalgarno, R E Klevit, B A Levine, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Selective inhibition of Src SH2 by a novel thiol-targeting tricarbonyl-modified inhibitor and mechanistic analysis by (1)H/(13)C NMR spectroscopyR Sundaramoorthi, C Siedem, C B Vu, et al.
Journal of Medicinal Chemistry|October 29, 2000
Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domainW C Shakespeare, R S Bohacek, M D Azimioara, et al.
Journal of Medicinal Chemistry|March 23, 2001
X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitorR S Bohacek, D C Dalgarno, M Hatada, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discoveryT K Sawyer, W C Shakespeare, Y Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domainN Kawahata, M G Yang, G P Luke, et al.
Bone|February 13, 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorptionS M Violette, W Guan, C Bartlett, et al.
Pageof 3